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Aims: To describe all outcome parameters and definitions of cure used to report on
outcome of surgical interventions for stress urinary incontinence (SUI) in neuro-
urological (NU) patients.
Methods: This systematic review was performed and reported according to the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
statement. The study protocol was registered and published (CRD42016033303;
http://www.crd.york.ac.uk/PROSPERO). Medline, Embase, Cochrane controlled
trials databases, and clinicaltrial.gov were systematically searched for relevant
publications until February 2017.
Results:A total of 3168 abstracts were screened. Seventeen studies reporting on SUI
surgeries in NU patients were included. Sixteen different outcome parameters and
nine definitions of cure were used. Six studies reported on objective outcome
parameters mainly derived from urodynamic investigations. All studies reported on
one or more subjective outcome parameters. Patient-reported pad use (reported
during interview) was the most commonly used outcome parameter. Only three of 17
studies used standardized questionnaires (two on impact of incontinence and one on
quality of life). Overall, a high risk of bias was found.
Conclusions: We found a considerable heterogeneity in outcome parameters and
definitions of cure used to report on outcome of surgical interventions for SUI in NU
patients. The results of this systematic review may begin the dialogue to a future
consensus on this topic. Standardization of outcome parameters and definitions of
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cure would enable researchers and clinicians to consistently compare outcomes of
different studies and therapies.
KEYWORDS
neurogenic, outcome assessment, patient reported outcome measures, stress urinary incontinence,
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1 | INTRODUCTION
Patients with neurological disease may show various
urological symptoms, depending on the type of disease
and the neurological location of the lesion.1,2 Both storage
and voiding problems can considerably reduce patients
quality of life.3 An impaired neurological control of the
external sphincter may be the cause of stress urinary
incontinence (SUI), defined as urinary incontinence that
occurs on exertion, effort, sneezing, or coughing.4 This
bothersome condition affects many neuro-urological (NU)
patients, typically those with a meningomyelocele or a
conus-cauda equina lesion.1 Owing to the fact that SUI in
NU patients often occurs together with other urological
dysfunction such as detrusor overactivity and reduced
bladder compliance,1,3 treatment of SUI in NU patients
requires a specific approach. Moreover, NU patients may
perceive bother from urinary incontinence differently
compared to non-NU patients due to altered sensation and
impaired mobility. Therefore, the outcome parameters and
the definitions of success or cure used to report on outcome
of surgical interventions for SUI in NU patients require
specific attention.
To identify the most appropriate therapy, studies on the
outcomes of the different therapies used to treat SUI in NU
patients should ideally be reported in a standardized way.
We performed a systematic review to describe all urinary
parameters and definitions of success or cure used to report
on outcome of surgical interventions for SUI in NU
patients.
2 | MATERIALS AND METHODS
2.1 | Study registration
The study protocol was registered and published on
PROSPERO (CRD42016033303) (http://www.crd.york.ac.
uk/PROSPERO). This systematic review was performed and
reported according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) state-
ment5 and Cochrane Handbook for Systematic Reviews of
Interventions.6
2.2 | Literature search
The Medline, Embase, Cochrane controlled trials databases,
and clinicaltrial.gov were systematically searched for all
relevant publications until February 2017. The search
strategy is available in Supplementary Material S1.
Duplicates were removed. No date restrictions were applied.
Non-English texts were excluded. Additionally, reference
lists of relevant reviews were hand-searched for missed
relevant articles.
2.3 | Study selection
Our aim was to include all publications of original studies
that used a predefined urinary outcome parameter or a
definition of success or cure to report on outcome of
surgical interventions for SUI in adult NU patients.
Conference abstracts, reviews, and case series with <10
NU patients were excluded. Reviews served only to check
the references for eligible extra articles. Studies with both
adult NU and non-NU patients or with both children and
adult NU patients were included only if adult NU patients
were separately reported on or if >90% of the study
population were adult NU patients.
Endnote (EndNote X7, Thomson Reuters, 1500 Spring
Garden Street, Fourth Floor, Philadelphia, PA 19130) was
used to store identified abstracts and to sort the abstracts for
inclusion and exclusion. Each title and abstract was
reviewed for eligibility by two out of four reviewing
authors (BB, JG, JS, SR) independently. Articles of which
the abstract met the eligibility criteria were reviewed in full
text. Full text selection was performed by two authors
independently (JG, SR) using a standardized screening
form. Discrepancy between the two authors was resolved by
discussion or by consulting a third reviewer (BB). We
reported on the literature search and study selection in a
PRISMA flow diagram.5
2.4 | Outcomes
All urinary outcome parameters and definitions of cure or
success used to report on outcome of surgical interventions
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for SUI in adult NU patients were summarized. Outcome
parameters containing information from questionnaires and
patient interviews were considered subjective outcome
parameters. Outcome parameters were considered objective
when derived from bladder diaries, pad tests, cough stress-
tests, or urodynamic investigations.
2.5 | Data extraction and risk of bias
assessment
Data on general study characteristics were retrieved by the first
author and checked by JG. Two authors (SR and JG)
independently extracted predefined data from the included
publications using a standardized data extraction form. A risk of
bias analysis for included non-randomized comparative studies
was performed by using the Cochrane Risk of bias Assessment
Tool7 in combination with an assessment of the main
confounders following the recommendations of the Cochrane
handbook for non-randomized comparative studies.6 A list of
themain confounderswas developed and a priori agreed onwith
clinical content experts (EAUNeuro-Urologyguidelines panel).
Identified confounders were age, gender, mixed versus stress
incontinence, underlying NU pathology, perineal sensation,
previous treatments for SUI, and previous pelvic surgeries.
Confounders were determined for the studies during data
extraction. The confounding bias was classified as “high” if the
confounder was not considered or described, was imbalanced
between the groups or was unadjusted during analysis. The risk
of bias in non-comparative studies was determined by assessing
the attrition bias (incomplete outcome data), the reporting bias
(selective outcome reporting), and availability of an a priori
protocol. External validity of these studies was reported by
assessingwhether participantswere selected consecutively.This
is a pragmatic approach based onmethodological literature.8,9 In
addition, the main confounders were assessed for these studies.
The risk of bias figure was computed in Review Manager
(RevMan) version 5.3 (Copenhagen: The Nordic Cochrane
Centre, The Cochrane Collaboration, 2014).
2.6 | Subgroup analyses
Subgroup analyses were intended to be performed if there
would be sufficient data. Predefined subgroups were men
versus women, SUI versus mixed UI, underlying NU
pathology, and no versus one/more former surgeries with
potential effect on continence.
3 | RESULTS
3.1 | Search results
Figure 1 shows the PRISMA flow diagram of the literature
search and study selection. After screening of 3168 abstracts,
182 full texts were reviewed. Finally, 17 studies were
included in this systematic review.10–26
3.2 | Characteristics of included studies
The included studies were published between 1995 and
2017 and report the results of various SUI surgeries. Table 1
shows the descriptives of the included studies. Most studies
had a retrospective single-arm study design. With one
exception, all studies were single-center studies. Twelve
studies reported on NU patients only. A total of 452 NU
patients were included in the studies. Most studies included
mixed patient populations regarding underlying NU
pathology, detrusor overactivity, mixed urinary inconti-
nence and pure SUI, and patients with and without previous
SUI, and other pelvic surgeries.
3.3 | Results on outcome parameters
Table 2 shows the outcome parameters used per study. In
total, 16 different outcome parameters were used in the 17
included studies. Furthermore categorization of the out-
comes differed (eg, patient-reported leakage/continence).
Eleven studies had applied two or more outcome param-
eters. Six of the 17 studies reported on both an objective and
a subjective outcome parameter.
FIGURE 1 PRISMA flow diagram of identified, excluded, and
included studies. NU, neuro-urological; SUI, stress urinary
incontinence
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3.3.1 | Objective outcome parameters
Six of 17 (35.3%) included studies reported on objective
outcome parameters. Pad tests were not reported on. In one
study, patients used a bladder diary to report the number of
urinary incontinence episodes per day. One study reported the
results of a cough stress-test. Urodynamics was the most used
investigation tomeasure an objective outcome parameter; that
is, in five studies. Bladder capacity, compliance, maximum
detrusor pressure, postvoid residual volume, leakage during
videocystometrogram, and Valsalva leak point pressure were
the objective outcome parameters that were derived from
urodynamic investigations.
3.3.2 | Subjective outcome parameters
Patient-reported pad use (number of pads/24 h or yes/no
daily pad use reported during an interview) was the most
utilized outcome parameter; used in eleven studies. Three
studies applied standardized questionnaires. In seven
studies patients reported on their urinary leakage status in
a post-intervention interview. Two studies reported on
patient satisfaction.
3.4 | Results on definition of success or cure
Table 3 provides an overview of the different definitions for
cure or continence used. Fifteen of 17 studies reported on
such a definition. In these 15 studies, nine different
definitions were used. Only two of five studies that reported
on cure and used an objective and a subjective outcome
parameter, used a combination of both outcomes to define
cure.
3.5 | Subgroup analyses
It was not contributive or possible to perform subgroup
analyses. First, the number of included studies was small;
second, because most studies identified included mixed
populations (gender, underlying NU pathology, SUI, and
mixed UI, former surgeries with potential effect on
continence); and finally, subanalyses and information on
predefined groups was often missing (Table 1).
3.6 | Risk of bias assessment
Most of the included studies were assessed as having high or
unclear risk of bias (Figure 2). In most retrospective studies, it
was unclear if an a priori protocol was available and if there
was selective outcome reporting. In one third of these studies,
it was unclear if there were incomplete outcome data. Most
studies included study participants consecutively. The two
comparative studies had a high risk of bias for most assessed
factors of the Cochrane Risk of bias Assessment Tool and the
confounding factors.
TABLE 3 Used definitions of cure or continence to report on success of surgical interventions for SUI in adult NU patients
Study Cure/continence Definition used
Pannek et al10 Cure No pads or continence aids used
Phé et al11 Continence No pad use
Losco et al12 Continent status = dry If patient reported complete correction of SUI + no pads usage
El-Azab et al13 Cure Negative cough stress test + no leakage during physical
examination
Costa et al14 Fully continent Patient-reported “fully continent”
Mehnert et al15 NR NR
Groen et al16 Cure Score of 10 on VAS (indicating no incontinence) or using no pads
Athanasopoulos et al17 Cure No leakage per urethra, 0 pads per day.
Chartier Kastler et al18 Perfect continence Dryness at least 4 h between two catheterizations/micturitions
Abdul-Rahman et al19 Cure Completely dry, no pads
Bersch et al20 Cure Subjective cure (no pads or continence aids) + objective cure
(continence confirmed during urodynamic investigation)
Ramsay et al21 Socially continent 0 or 1 pads/day
Lai et al22 NR NR
Hamid et al23 Cure Cessation of using pads and dry on VCMG
Costa et al24 Continence Patient reporting no leakage and no use of pads
Bennett et al25 Cure Patient reporting no leakage
Nataluk et al26 Continent or total continence Totally dry on postoperative interview
NR, not reported; NU, neuro-urological; SUI, stress urinary incontinence; VCMG, videocystometrogram.
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4 | DISCUSSION
4.1 | Principal findings
In this systematic review, we have presented all
parameters and definitions of cure to report on the
outcome of surgical interventions for SUI in adult NU
patients. Sixteen different outcome parameters and nine
different definitions of cure or continence were used.
Most outcomes and definitions of cure were based on
non-standardized patient self-assessments (of pad use per
day or leakage/continence). A minority of studies made
use of objective outcome parameters or validated
questionnaires. To the best of our knowledge, this is
the first systematic review on this topic in this specific
patient group. It is evident that there is a considerable
heterogeneity in the urinary outcome parameters and
definitions of cure used to report on outcome of surgical
interventions for SUI in adult NU patients.
4.2 | Findings in the context of the existing
evidence
The heterogeneity of outcome reportingmakes itmore difficult
to interpret and compare different studies and therapies. The
Core Outcome Measures in Effectiveness Trials (COMET)
initiative supports the development of standardized sets of
outcomes in all fields of health research.27 In the field of
urology such core outcome sets are available for prostate
cancer and male sexual dysfunction, but not for UI. The
FIGURE 2 Risk of bias summary. NU, neuro-urological; SUI, stress urinary incontinence
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International Continence Society (ICS) and the International
Consultation on Incontinence (ICI) recommend using both
objective and subjective outcome parameters in UI
research.28,29 Despite this, these organizations do not provide
a definition of cure or make recommendations for the specific
outcome parameters to be used.
Specifically, in the field of NU patients undergoing SUI
surgery there is no consensus on outcome parameters. The
ICS does not provide a recommendation on this topic for
research in NU patients. The ICI recommends using changes
in detrusor leak point pressure for research purposes in NU
patients if appropriate.28 Nevertheless, this parameter was not
used in any of the included studies in our systematic review.
The EAU guidelines mention prevention of deterioration of
the upper urinary tract and optimization of the quality of life
as the most important urological treatment goals for NU
patients.30 Therefore, we would expect urodynamic inves-
tigations and quality of life measures to be used more often in
this patient group. NU patients may have altered sensation
and impaired mobility and consequently perceive (UI)
complaints different than to non-NU patients. Thus, measur-
ing patients’ perception of UI complaints and their health-
related quality of life (rather than quantifying symptoms) is
important, especially in this patient group. Phé et al31 and
Castillo et al32 reported in their reviews on the commonly
used outcome parameters and definitions of cure or treatment
success used after SUI surgery (not specifically on NU
patients). Phé et al31 reviewed publications on all SUI
surgeries from 1995 to 2014 and Castillo et al32 focused on
publications on female SUI from 2005 and 2006. In our
systematic review, we found that five out of 17 (29.4%)
included studies used outcome parameters derived from
urodynamic investigations. Phé et al31 and Castillo et al32
found that urodynamic investigations were performed in 12 of
54 studies (22.2%) and in 37 of 92 studies (40.2%),
respectively. Only two of the 17 (11.8%) studies in our
review applied questionnaires on the impact of UI and only
one study used quality-of-life assessments. The question-
naires administered were the UDI-6, IIQ-7, visual analog
scale for continence, and ICIQ male short form. These are
validated questionnaires, but not specifically for NU patients.
Although validated (disease-specific) quality of life ques-
tionnaires such as the (SF-)Qualiveen33,34 have been
introduced in the recent past, they have not always been
available. In the review by Phé et al31 validated questionnaires
(including quality of life measures) were used in 55.6% and in
the review by Castillo et al32 validated questionnaires were
used in 40.2% and quality of life measures were used in 60.9%
of the studies. So contrary to our expectations, urodynamic
investigations and quality of lifemeasureswere not usedmore
often in our systematic review in NU patients. For
retrospective studies, only available measures from clinical
practice can be used. The high number of retrospective studies
in our systematic review compared to Phé et al31 and Castillo
et al32 could explain the different findings. On the other hand,
one would expect quality of life measures and urodynamic
investigations as standard of care in NU patients.
Despite the ICS and ICI recommendations, in only sixof 17
(35.3%) included studies in this systematic review both a
subjective and an objective outcome parameter was used and
only two of these studies used a combination of these
parameters to define cure. Compared to the reviews of Phé et
al31 and Castillo et al32 in non-neurological patients, where
about half of the studies reported on both a subjective and an
objective outcome, this number is low. The high number of
retrospective studies could again be an explanation for this
finding. Comparable to our results, in the reviews of Phé et al31
and Castillo et al32 a minority of studies used a combination of
subjective and objective outcome parameters to define cure.
Pad use reported by the patient during an interview was the
most used outcome parameter in the studies included in our
systematic review. Phé et al31 reported on this outcome for some
studies, but not structurally for all and Castillo et al.32 did not
mention this outcome parameter in their review. In one included
study17 of our review this outcome parameter was chosen
because it would reflect the quality of life, referring to a
publication by Stoffel et al35 that found a correlation between
patient-reported pad use and the impact of UI on quality of life.
In other publications the reason for choosing this outcome
parameter is not clear, but might be the ease of collecting this
information (especially for retrospective series) for both patient
and researcher; in addition it does not interfere in a patient's
“normal daily voiding routine” (as a bladder diarymight do). It is
questionable if patient-reported pad use during an interview
reflects the quantity of urine lost36 specifically for NU patients
with altered sensation in whom the use of incontinence pads is
often discouraged to prevent skin problems. Furthermore, it is
unknown if patient-reported pad use is comparable to bladder
diary reported pad use. As using this outcome parametermay be
advantageous, we suggest to further investigate this outcome
parameter on psychometric properties, such as test-retest
reliability, correlation with bladder diary reported pad use,
quantity of urine lost, and quality of life.
4.3 | Implication for research and clinical
practice
Farag et al37 reported on the success rates of surgical treatments
for SUI in both adult and pediatric NU patients in a systematic
review. Farag et al37 compared the combined success rates of
the included studies on urethral bulking agents to urethral sling
procedures and artificial urinary sphincters. These studies
however used variable definitions of success. A consistent
comparison of the outcomes of therapy can only be made after
standardization of outcome parameters and definitions of cure
or success. We therefore recommend developing a core
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outcome set for use in UI research with NU patients. It is
important that not only medical experts, but also patients and
caregivers will be involved in the development of this outcome
set, in order to include the various perspectives and also to
increase the willingness to implement the outcome set. Until
such a set has been developed, we recommend using an
objective and a subjective outcome parameter and the
combination of both to define cure. Because of the importance
of the quality of life, specifically in NU patients, we
recommend the use of a disease-specific quality of life
questionnaire or a bother questionnaire validated for NU
patients such as the (SF-)Qualiveen33,34 as a subjective
outcome parameter. Implementing such questionnaires in
both research and clinical practice places a focus on
optimization of the quality of life for these patients and makes
it possible to compare outcomes of different studies. A clear
recommendation for the use of a specific objective parameter is
not feasible because there is insufficient scientific evidence on
the psychometric properties of the different objectivemeasures
(bladder diaries, urodynamics, and pad tests), specifically
regarding NU patients.38
4.4 | Strengths and limitations
Performing this systematic review, we followed the recom-
mended Cochrane6 and PRISMA guidelines.5 Our study gives
a clear overview of all used urinary parameters and definitions
of success or cure to report on the outcome of surgical
interventions for SUI in NU patients, and will hopefully begin
the dialogue to a future consensus on this topic. Unfortunately,
the included studies were primarily retrospective and of poor
scientific quality. Furthermore, subgroup analyses were not
possible due to the limited number of included studies.
5 | CONCLUSIONS
This is the first systematic review that has evaluated the
various urinary parameters and definitions of cure to report on
outcome after surgery for SUI in adult NU patients. We found
a considerable heterogeneity in used outcome parameters and
definitions of cure. As it is difficult to interpret and compare
the outcomes of different therapies as investigators use
different reporting systems of outcomes and definitions of
cure, the results of this studywill hopefully begin the dialogue
to a future consensus on this topic.
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